A court judgment proves OPay granted share options in 2020. Its US filing never mentions them, and investors are left to guess whether that’s a gap or a non-issue.
A court judgment proves OPay granted share options in 2020. Its US filing never mentions them, and investors are left to guess whether that’s a gap or a non-issue.
With 80% of its €50m impact fund deployed, Boehringer Ingelheim is backing startups tackling last-mile medicine delivery, e-pharmacy, and affordable outpatient care.
